Alexei Korchounov

Summary

Country: Germany

Publications

  1. ncbi Determinants of autonomic dysfunction in idiopathic Parkinson's disease
    Alexei Korchounov
    Parkinson Clinic Bad Nauheim, Franz Groedel Str 6, 61231 Bad Nauheim, Germany
    J Neurol 252:1530-6. 2005
  2. ncbi Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease
    Alexei Korchounov
    Department of Neurology, J W Goethe University, Frankfurt Main, Germany
    Mov Disord 19:1059-64. 2004
  3. ncbi Employment, medical absenteeism, and disability perception in Parkinson's disease: A pilot double-blind, randomized, placebo-controlled study of entacapone adjunctive therapy
    Alexei Korchounov
    Parkinson Clinic, Bad Nauheim, Germany
    Mov Disord 21:2220-4. 2006
  4. ncbi Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Matthias Oechsner
    Parkinsonklinik Bad Nauheim, Germany
    Hum Psychopharmacol 20:203-5. 2005

Detail Information

Publications4

  1. ncbi Determinants of autonomic dysfunction in idiopathic Parkinson's disease
    Alexei Korchounov
    Parkinson Clinic Bad Nauheim, Franz Groedel Str 6, 61231 Bad Nauheim, Germany
    J Neurol 252:1530-6. 2005
    ..To determine demographic or disease-related factors that may influence the severity of autonomic dysfunction in idiopathic Parkinson's disease (IPD)...
  2. ncbi Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease
    Alexei Korchounov
    Department of Neurology, J W Goethe University, Frankfurt Main, Germany
    Mov Disord 19:1059-64. 2004
    ..7) and ART-EO (odds ratio = 7.8), but not with MT or ART-LO patients. Segregation analysis suggested an autosomal recessive mode of transmission in ART-EO and an autosomal dominant mode of transmission in TDT...
  3. ncbi Employment, medical absenteeism, and disability perception in Parkinson's disease: A pilot double-blind, randomized, placebo-controlled study of entacapone adjunctive therapy
    Alexei Korchounov
    Parkinson Clinic, Bad Nauheim, Germany
    Mov Disord 21:2220-4. 2006
    ..In this pilot study, LD with ENT adjunctive therapy positively influenced employment rate over 2 years; this effect was associated with reduced motor complications and patient perceptions of stabilized disability...
  4. ncbi Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Matthias Oechsner
    Parkinsonklinik Bad Nauheim, Germany
    Hum Psychopharmacol 20:203-5. 2005
    ..No deterioration of motor function or other clinically relevant side effects were seen...